Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 31725351

Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Jan 1
First author
Le DT

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2020 Feb;17(2):68. doi: 10.1038/s41571-019-0310-5.
    note
    Source null
    related pmid
    31831852
    relationship
    Comment in

Authors and identifiers

  1. name
    Le DT
    type
    Author
  2. name
    Kim TW
    type
    Author
  3. name
    Van Cutsem E
    type
    Author
  4. name
    Geva R
    type
    Author
  5. name
    Jäger D
    type
    Author
  6. name
    Hara H
    type
    Author
  7. name
    Burge M
    type
    Author
  8. name
    O'Neil B
    type
    Author
  9. name
    Kavan P
    type
    Author
  10. name
    Yoshino T
    type
    Author
  11. name
    Guimbaud R
    type
    Author
  12. name
    Taniguchi H
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Le DT
    type
    Author
  2. name
    Kim TW
    type
    Author
  3. name
    Van Cutsem E
    type
    Author
  4. name
    Geva R
    type
    Author
  5. name
    Jäger D
    type
    Author
  6. name
    Hara H
    type
    Author
  7. name
    Burge M
    type
    Author
  8. name
    O'Neil B
    type
    Author
  9. name
    Kavan P
    type
    Author
  10. name
    Yoshino T
    type
    Author
  11. name
    Guimbaud R
    type
    Author
  12. name
    Taniguchi H
    type
    Author
bibliography ids
  1. nci-bib-5122f2a2fae2ca5ec995cf00
book metadata
content sha256
9e822bd7a5c30db7efa899ceebcfe0bd331e4f1a97219337840887ec1cc72ad4
document type
citation
dois
  1. 10.1200/JCO.19.02107
electronic publication date
display
2019 Nov 14
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31725351
immutable id
pubmed:31725351@9e822bd7a5c30db7efa899ceebcfe0bd331e4f1a97219337840887ec1cc72ad4
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
1
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
11-19
volume
38
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2020 Feb;17(2):68. doi: 10.1038/s41571-019-0310-5.
    note
    Source null
    related pmid
    31831852
    relationship
    Comment in
outcomes validated
false
pmid
31725351
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
989f555e29262ee941859f33f47d9192fd27feb7702d39af272a9d531cafd97a
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2020 Jan 1
precision
day
year
2020
publication types
  1. Clinical Trial, Phase II
  2. Journal Article
  3. Multicenter Study
  4. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31725351/
title
Phase II Open-Label Study of Pembrolizumab in Treatment-Refractory, Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: KEYNOTE-164.

Preserved source evidence · Independent clinical review pending · Not medical advice